Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Curreen Capital Christian Ryther | “While Enhabit has been doing fairly well with its turnaround, I did not like the increasing headwinds facing the business and decided that we would be better off investing our money elsewhere. In early July, the Centers for Medicare and Medicaid Services (CMS) proposed cutting Medicare home health reimbursement rates even more aggressively than they have in the past few years. Medicare is Enhabit's best-paying customer, and this cut—deeper than those of the past few years—was unexpected. With the prospect of not only continuing rate cuts but even deeper rate cuts, I reduced my valuation for the company. Enhabit has navigated the home health industry headwinds well so far, and its Hospice business is doing very well, but the headwinds are worse than I thought. As the U.S. population ages, demand for home health services will grow, but getting CMS and insurers to pay the rates that will allow home health companies to profitably expand supply now appears more challenging than I had expected. BSD Analysis: Curreen Capital exited Enhabit due to structural reimbursement headwinds and regulatory uncertainty. CMS rate cuts compress margins in a fixed-cost industry, and while demographics are favorable, policy risk and limited pricing leverage cap upside. With forward EV/EBITDA ~8x and stagnant earnings visibility, redeployment to higher-growth, less policy-sensitive names is prudent.” | BEAR | Q3 2025 Sep 30, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
